Purchases and Sales Made in Q3 2022 in Fennec Pharmaceuticals Inc. (FENC)
This table provides information about the institutional ownership of Fennec Pharmaceuticals Inc. (FENC) during Q3 2022. The information is specifically focused on institutions that hold shares of FENNEC PHARMACEUTICALS INC..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2022
Q3 2022
|
Eam Investors, LLC
Solana Beach, CA |
BUY
|
- |
177KNew |
$1.01M - $1.51M
|
177K
$1.14M
|
|
Nov 14, 2022
Q3 2022
|
Tamarack Advisers, LP
Carlsbad, CA |
BUY
|
- |
175KNew |
$999K - $1.49M
|
175K
$1.13M
|
|
Nov 14, 2022
Q3 2022
|
Jefferies Group LLC
New York, NY |
BUY
|
- |
34.5KNew |
$197K - $295K
|
34.5K
$223K
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
15.7KNew |
$89.5K - $134K
|
15.7K
$101K
|
|
Nov 09, 2022
Q3 2022
|
Group One Trading, L.P.
Chicago, IL |
BUY
|
- |
14.9KNew |
$85.2K - $127K
|
14.9K
$96.6K
|
|
Nov 14, 2022
Q3 2022
|
Jane Street Group, LLC
New York, NY |
BUY
|
- |
14.5KNew |
$82.8K - $124K
|
14.5K
$93.9K
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
11.9K+ 5.03% |
$68.2K - $102K
|
249K
$1.61M
|
|
Oct 25, 2022
Q3 2022
|
Hartford Financial Management Inc.
|
BUY
|
- |
5K+ 14.35% |
$28.6K - $42.7K
|
39.8K
$258K
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
BUY
|
- |
3.04K+ 4742.19% |
$17.3K - $25.9K
|
3.1K
$20.1K
|
|
Nov 14, 2022
Q3 2022
|
Ancora Advisors, LLC
Cleveland, OH |
BUY
|
- |
1.25K+ 20.75% |
$7.11K - $10.6K
|
7.25K
$46.9K
|
|
Oct 25, 2022
Q3 2022
|
Cutler Group LP
|
BUY
|
- |
139New |
$794 - $1.19K
|
139
$899
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 14, 2022
Q3 2022
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-110- 0.98% |
$628 - $939
|
11.1K
$71.9K
|
|
Nov 14, 2022
Q3 2022
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-259- 94.87% |
$1.48K - $2.21K
|
14
$90.6
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-366- 9.2% |
$2.09K - $3.13K
|
3.61K
$23.4K
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-2K- 3.9% |
$11.4K - $17.1K
|
49.4K
$319K
|
|
Nov 14, 2022
Q3 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-2.34K- 47.19% |
$13.4K - $20K
|
2.62K
$17K
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-4.28K- 10.61% |
$24.4K - $36.5K
|
36.1K
$233K
|
|
Nov 14, 2022
Q3 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-7.67K- 99.1% |
$43.8K - $65.5K
|
70
$453
|
|
Nov 14, 2022
Q3 2022
|
683 Capital Management, LLC
New York, NY |
SELL
|
- |
-40.5K- 9.53% |
$231K - $346K
|
385K
$2.49M
|
|
Nov 14, 2022
Q3 2022
|
Solas Capital Management, LLC
Darien, CT |
SELL
|
- |
-42.3K- 3.61% |
$242K - $362K
|
1.13M
$7.32M
|
|
Nov 14, 2022
Q3 2022
|
Dg Capital Management, LLC
New York, NY |
SELL
|
- |
-206K- 16.98% |
$1.17M - $1.76M
|
1.01M
$6.5M
|